title: Resolution of musculoskeletal symptoms in the carcinoid syndrome after treatment with the somatostatin analog octreotide.
authors.affiliation: Vanderbilt University School of Medicine, Nashville, Tennessee.
authors.forename: S
authors.initials: S
authors.lastname: Smith
authors.forename: L
authors.initials: L
authors.lastname: Anthony
authors.forename: L J
authors.initials: LJ
authors.lastname: Roberts
authors.forename: J A
authors.initials: JA
authors.lastname: Oates
authors.forename: T
authors.initials: T
authors.lastname: Pincus
mesh_terms: D000368:Aged; D001847:Bone Diseases / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy* / Q000209:etiology; D015282:Octreotide / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy / Q000209:etiology
chemical_list: D015282:Octreotide